Acromegaloid Facial Appearance Syndrome Overview
Learn About Acromegaloid Facial Appearance Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Trustees Of Columbia University In The City Of New York
Jeffrey Bruce is a Neurosurgery provider in New York, New York. Dr. Bruce and is rated as a Distinguished provider by MediFind in the treatment of Acromegaloid Facial Appearance Syndrome. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Gamma Knife Radiosurgery, and Awake Craniotomy.
Trustees Of Columbia University In The City Of New York
Pamela Freda is an Endocrinologist in New York, New York. Dr. Freda and is rated as an Elite provider by MediFind in the treatment of Acromegaloid Facial Appearance Syndrome. Her top areas of expertise are Acromegaly, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Acromegaloid Facial Appearance Syndrome, and Pituitary Tumor.
Memorial Endocrine Group
Eliza Geer is an Endocrinologist in New York, New York. Dr. Geer and is rated as a Distinguished provider by MediFind in the treatment of Acromegaloid Facial Appearance Syndrome. Her top areas of expertise are Cushing's disease, Cushing's syndrome, Pituitary Tumor, and Hypothalamic Tumor.
Summary: PAMSARC is a non-commercial interventional Phase 2 clinical trial of academic research institutions, with its primary goal being to improve medical treatment of fusion driven Desmoplastic small round cell tumor (DSRCT) and Synovial sarcoma (SySa) in young adults and adolsecents with male predominance. Current management of DSRCT and SySa includes chemotherapy, radiation and aggressive cytoreductiv...
Background: For children with gigantism, too much growth hormone (GH) in the body causes abnormal growth and many other problems. Current treatments often don t work; no medical treatment is approved by FDA. Researchers want to see if the drug pegvisomant can help.